Brief: Australian Clinical Labs Announces Extension Of Takeover Offer Period For Healius Ltd
Nov 1 (Reuters) - Australian Clinical Labs Ltd ACL.AX :
* TAKEOVER OFFER FOR HEALIUS LIMITED - EXTENSION OF OFFER
PERIOD
* DETERMINED TO FURTHER EXTEND END OF OFFER PERIOD UNTIL
7:00PM
(SYDNEY TIME) ON 29 FEB 2024
* NOTES ACCC HAS NOT PUBLICLY STATED ACL OF DATE ON WHICH
ACCC
EXPECTS TO ANNOUNCE ITS FINAL DECISION FOR PROPOSED MERGER
* RESOLVED TO POSTPONE ACL EGM TO 16 FEBRUARY 2024
Source text for Eikon: ID:nASX9kJcRG
Further company coverage: ACL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Healius
See all newsAustralia's Healius rises on sale of unit Agilex; Jefferies lifts PT
Brief: Healius To Sell Agilex Biolabs To Novotech
Australia's Healius rises on sale of unit Agilex Biolabs to Novotech Health
Brief: Healius Requests Trading Halt
Brief: Healius Expects To Achieve T27 Target Of Mid-To-High Single-Digit EBIT Margins By Dec 2028